The day the U.S. Supreme Court overturned Roe v. Wade in 2022, the medical board that certifies OB-GYNs in America released a statement calling legal pregnancy termination and knowledge of abortion procedures “essential to reproductive health care.”

Double the costs, double the travel, double the child care. Those were the stories of some who struggled to receive abortion care because of Ohio’s 24-hour waiting period and two-visit mandates, according to a new court brief in a lawsuit attempting to eliminate the regulations.

The U.S. Senate gridlocked over reproductive rights on Wednesday, when Republicans blocked Democrats from advancing a measure that would have expressed support for abortion access.

Clinic closures in the wake of the Dobbs decision and questions about the legality of emergency contraceptives, including disinformation that some are abortion drugs, may have contributed to a sharp drop in the rate of prescriptions for contraceptives in states with the most restrictive abortion bans, according to a University of California Los Angeles study.

Exactly two years after the U.S. Supreme Court overturned the constitutional right to an abortion, the battles rage among both advocates and lawmakers over the future of reproductive rights at the state and federal levels.

In Arizona, the state’s highest court upheld a Civil War-era abortion ban. Florida and South Carolina moved to restrict abortion to six weeks — before many people know they are pregnant. The Alabama Supreme Court ruled that frozen embryos are “children,” temporarily throwing fertility treatments, such as IVF, into uncertainty and igniting a national debate.

It’s been two years since the U.S. Supreme Court’s Dobbs decision sent the question of abortion rights back to the states, and despite new constitutional protections in Ohio, Democrats believe it remains a potent political issue.

In the aftermath of the U.S. Supreme Court’s unanimous ruling last week to maintain current access to the abortion medication mifepristone, abortion-rights advocates and opponents vowed to continue their respective battles over the drug.

When Lauren Miller flew from her home state of Texas to Colorado two years ago she felt a moment of relief when the plane took off — not because she had been delayed for hours or because she needed a vacation, but because she was about to meet with doctors who would be able to treat her complicated pregnancy with twins.

The U.S. Supreme Court ruled in a much-anticipated decision Thursday that mifepristone, one of two pharmaceuticals used in medication abortion, can remain available under current prescribing guidelines.

The national debate over whether laws or patients should determine abortion access dominated a U.S. Senate committee hearing Tuesday, when a panel of six experts testified about the complicated nature of treating pregnancies and miscarriages.

Years before the Dobbs decision, providers like Dr. Kylie Cooper were already uncomfortable with some of the reporting requirements for abortion procedures in states where they practiced.

Doctors from throughout the country posted a public letter last week, urging the U.S. Supreme Court to ensure health care professionals can perform abortions in every state when that procedure is essential “stabilizing treatment” under the Emergency Medical Treatment and Active Labor Act.

Signature gatherers for and against Nebraska’s abortion restrictions soon will have company from circulators of a third ballot initiative on the issue.

The Louisiana Legislature gave final approval Thursday to a bill that would label two drugs used to induce labor and treat miscarriages as “controlled dangerous substances,” despite opposition from a broad group of medical professionals.